Drug Makers Expedite Switch OTC Development, Sales After Japan Law Revision
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japanese drug makers are stepping up development and sales of switch OTC drugs with the hope of gaining market share, a continuing ripple effect from the recent amendment on OTC pharmaceuticals